68 research outputs found

    Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children.

    Get PDF
    OBJECTIVES: The objectives of this study were to investigate the population pharmacokinetics of posaconazole in immunocompromised children, evaluate the influence of patient characteristics on posaconazole exposure and perform simulations to recommend optimal starting doses. METHODS: Posaconazole plasma concentrations from paediatric patients undergoing therapeutic drug monitoring were extracted from a tertiary paediatric hospital database. These were merged with covariates collected from electronic sources and case-note reviews. An allometrically scaled population-pharmacokinetic model was developed to investigate the effect of tablet and suspension relative bioavailability, nonlinear bioavailability of suspension, followed by a step-wise covariate model building exercise to identify other important sources of variability. RESULTS: A total of 338 posaconazole plasma concentrations samples were taken from 117 children aged 5 months to 18 years. A one-compartment model was used, with tablet apparent clearance standardised to a 70-kg individual of 15 L/h. Suspension was found to have decreasing bioavailability with increasing dose; the estimated suspension dose to yield half the tablet bioavailability was 99 mg/m2. Diarrhoea and proton pump inhibitors were also associated with reduced suspension bioavailability. CONCLUSIONS: In the largest population-pharmacokinetic study to date in children, we have found similar covariate effects to those seen in adults, but low bioavailability of suspension in patients with diarrhoea or those taking concurrent proton pump inhibitors, which may in particular limit the use of posaconazole in these patients

    How the viewing of familiar landscapes prior to release allows pigeons to home faster: evidence from GPS tracking.

    No full text
    Providing homing pigeons with a 5 min preview of the landscape at familiar sites prior to release reliably improves the birds' subsequent homing speeds. This phenomenon has been taken to suggest that the visual panorama is involved in familiar-site recognition, yet the exact nature of the improvement has never been elucidated. We employed newly developed miniature Global Positioning System (GPS) tracking technology to investigate how access to visual cues prior to release affects pigeons' flight along the length of the homing route. By applying a variety of novel analytical techniques enabled by the high-resolution GPS data (track efficiency, virtual vanishing bearings, orientation threshold), we localised the preview effect to the first 1000 m of the journey. Birds denied preview of a familiar landscape for 5 min before take-off flew an initially more tortuous path, including a high incidence of circling, possibly as part of an information-gathering strategy to determine their position. Beyond the first 1000 m, no differences were found in the performance of birds with or without preview. That the effect of the visual treatment was evident only in the early part of the journey suggests that lack of access to visual cues prior to release does not result in a non-specific effect on behaviour that is maintained throughout the flight. Instead, it seems that at least some decisions regarding the direction of home can be made prior to release and that such decisions are delayed if visual access to the landscape is denied. Overall, the variety of approaches applied here clearly highlight the potential for future applications of GPS tracking technology in navigation studies

    Hepatic Biotransformation

    No full text
    corecore